HLA-C and myeloid sarcoma: al. showed MS risk variants are associated with alternative splicing in C-Type Lectin Domain Containing 16A (CLEC16A), EF-Hand Calcium Binding Domain 13 (EFCAB13), Gasdermin B (GSDMB), Major Histocompatibility Complex, Class I, C (HLA-C), Interleukin 7 Receptor (IL7R), Non-SMC Condensin II Complex Subunit H2 (NCAPH2), SP140 Nuclear Body Protein (SP140), and Ts Translation Elongation Factor, Mitochondrial (TSFM) genes [9].